What drove the DOCM.SW stock gain today?

DOCM.SW stock rose **5.16%** on 10 Feb 2026 on a technical rebound, sector support from Healthcare, and positioning ahead of the **19 Mar 2026** earnings release. Volume was **144,654**, below average, indicating selective buying rather than broad conviction.

What is Meyka AI's forecast for DOCM.SW stock?

Meyka AI's forecast model projects **CHF 6.50** monthly for DOCM.SW stock (implied **+9.98%**). The model also gives a quarterly scenario of **CHF 16.47**. Forecasts are model-based projections and not guarantees.

Is DOCM.SW stock a value buy based on current ratios?

DOCM.SW shows low valuation multiples (**P/S 0.27**, **P/B 0.36**) and strong liquidity, but negative EPS (**-4.58**) and weak cash flow argue caution. Value upside exists, but profitability recovery is needed to justify a buy.

When is the next DOCM.SW earnings report and why it matters?

DocMorris AG reports earnings on **19 Mar 2026**. The results and guidance matter because they can shift sentiment on margins, cash flow and validate the Meyka AI short-term forecast or increase downside risk.

CH Stocks

DOCM.SW DocMorris AG (SIX) up 5.16% on 10 Feb 2026: model flags 9.98% monthly upside

ByDanny Kontos February 11, 2026February 11, 2026

DOCM.SW stock led Swiss gainers on 10 Feb 2026, closing at CHF 5.91, up 5.16% as traders reacted to a short-term technical rebound. Volume reached 144,654 shares versus a 50-day average of 322,651, showing a smaller-than-normal participation. We see the move as a tactical bounce inside a longer downtrend from the year high CHF 24.90 to the current level. The intraday range was CHF 5.65–5.95 and the next catalyst is the earnings report scheduled for 19 Mar 2026. This piece examines drivers, ratios, technicals and Meyka AI forecasts for DOCM.SW stock on SIX in Switzerland.